from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3774/echA21

LFCtreatmentdescriptionclass of inhibitor

0.342

Amikacinug/mL Amikacintranslation

-0.426

Cap5-10ug/mL Capreomycintranslation

-1.688

Rox10-50 ug/mL Roxithromycintranslation

1.466

SM2-5 ug/mL Streptomycintranslation

-1.548

Tet5-10 ug/mL Tetracyclinetranslation

-1.741

Rif0.2-5ug/mL Rifampicintranscription

-1.628

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.274

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.627

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.664

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.861

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.097

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.204

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.370

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.381

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.064

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.323

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.758

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.444

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.437

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.171

KCN5-20 ug/mL Potassium cyaniderespiration

1.151

NaN30.2-2 mM Sodium aziderespiration

0.499

Nigericin50 uM Nigericinrespiration

-0.527

TRC10-150 ug/mL Triclosanrespiration

-1.604

TRZ10-25 ug/mL Thioridazinerespiration

-0.370

Valinomycin0.5-10 uM Valinomycinrespiration

0.500

ZnSO42 mM ZnSO4respiration

1.969

menadione6-10 ug/mL Menadionerespiration

-0.594

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.093

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.550

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.557

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.060

NRP_1Non-replicating persistence stage 1dosRassociated

0.091

Amp0.2mg/mL AmpicillincellWall

0.348

Cephalexin20-100 ug/mL CephalexincellWall

0.512

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.094

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.212

EMB10-20 ug/mL EthambutolcellWall

-0.071

Eta12-40 ug/mL EthionamidecellWall

-0.177

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.421

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.564

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.538

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.745

BZA0.12 mg/mL BenzamidearomaticAmides

0.739

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.788

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.141

H2O24 mM hydrogen peroxideDNAdamaging

0.454

Levo10 ug/mL LevofloxacinDNAdamaging

0.137

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.804

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.906

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.166

UVUV-irradiationDNAdamaging

0.394

ARP41-4 ug/mL Antitubercular compound ARP4?

0.459

Antimycin12.5-50 ug/mL Antimycin A?

0.252

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.839

PA_110-50 ug/mL Antitubercular compound PA-1?

0.708

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.148

PA8240.2-2 ug/mL PA-824?

-0.144

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.091

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.445

Verapamil50 uM Verapamil?

0.125

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.023

methoxatin10-20 ug/mL Methoxatin?